Prognostic value of plasma renin activity in heart failure patients with chronic kidney disease

International Journal of Cardiology

Volumn 167, Issue 3, 2013, Pages 711-715

  Poletti, Roberta ^a   Vergaro, Giuseppe ^a   Zyw, Luc ^a   Prontera, Concetta ^a   Passino, Claudio ^a,b   Emdin, Michele ^a  

^a CNR   (Italy)

^b SCUOLA SUPERIORE SANT ANNA   (Italy)

Author keywords

Chronic heart failure; Chronic kidney disease; Natriuretic peptides; Plasma renin activity; Renin angiotensin system

Indexed keywords

ALDOSTERONE ANTAGONIST; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; NORADRENALIN;

AGED; ARTICLE; CARDIOVASCULAR MORTALITY; CHRONIC KIDNEY DISEASE; CLINICAL EXAMINATION; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEART DEATH; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HIGH RISK PATIENT; HORMONE DETERMINATION; HUMAN; KIDNEY DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; MEASUREMENT ACCURACY; NEUROLOGIC EXAMINATION; NORADRENALIN BLOOD LEVEL; PLASMA RENIN ACTIVITY; PREDICTIVE VALUE; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; REFERENCE VALUE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SYSTOLIC HEART FAILURE;

CHRONIC HEART FAILURE; CHRONIC KIDNEY DISEASE; NATRIURETIC PEPTIDES; PLASMA RENIN ACTIVITY; RENIN-ANGIOTENSIN SYSTEM;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; COMORBIDITY; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PROGNOSIS; PROSPECTIVE STUDIES; RENAL INSUFFICIENCY, CHRONIC; RENIN; SURVIVAL RATE;

EID: 84880924472     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2012.03.061     Document Type: Article

References (36)

1. K. Swedberg, P. Eneroth, J. Kjekshus, and L. Wilhelmsen Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group Circulation 82 1990 1730 1736
2. M. Packer Pathophysiology of chronic heart failure Lancet 340 1992 88 92
3. G.S. Francis, J.N. Cohn, G. Johnson, T.S. Rector, S. Goldman, and A. Simon Plasma norepinephrine, plasma renin activity, and congestive heart failure. Relations to survival and the effects of therapy in V-HeFT II. The V-HeFT VA Cooperative Studies Group Circulation 87 Suppl. 6 1993 VI40 VI48
4. C.R. Benedict, D.E. Johnstone, and D.H. Weiner Relation of neurohumoral activation to clinical variables and degree of ventricular dysfunction: a report from the Registry of Studies of Left Ventricular Dysfunction. SOLVD Investigators J Am Coll Cardiol 23 1994 1410 1420
5. R. Latini, S. Masson, and I. Anand The comparative prognostic value of plasma neurohormones at baseline in patients with heart failure enrolled in Val-HeFT Eur Heart J 25 2004 292 299
6. G. Vergaro, M. Emdin, and A. Iervasi Prognostic value of plasma renin activity in heart failure Am J Cardiol 108 2011 246 251
7. C. Ronco, P. McCullough, and S.D. Anker Acute Dialysis Quality Initiative (ADQI) consensus group. Cardio-renal syndromes: report from the consensus conference of the acute dialysis quality initiative Eur Heart J 31 2010 703 711
8. L.M. Ruilope, D.J. Van Veldhuisen, E. Ritz, and T.F. Luscher Renal function: the Cinderella of cardiovascular risk profile J Am Coll Cardiol 38 2001 1782 1787
9. T.D. Smilde, H.L. Hillege, A.A. Voors, P.H. Dunselman, and D.J. Van Veldhuisen Prognostic importance of renal function in patients with early heart failure and mild left ventricular dysfunction Am J Cardiol 94 2004 240 243
10. H.L. Hillege, A.R. Girbes, and P.J. de Kam Renal function, neurohormonal activation, and survival in patients with chronic heart failure Circulation 102 2000 203 210
11. Hl Hillege, D. Nitsch, and M.A. Pfeffer Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) Investigators. Renal function as a predictor of outcome in a broad spectrum of patients with heart failure Circulation 113 2006 671 678
12. T. Yamamoto, T. Nakagawa, and H. Suzuki Urinary angiotensinogen as a marker of intrarenal angiotensin II activity associated with deterioration of renal function in patients with chronic kidney disease J Am Soc Nephrol 18 2007 1558 1565
13. C.W. Mende Application of direct renin inhibition to chronic kidney disease CardioVasc Drugs Ther 24 2010 139 149
14. M. Emdin, C. Passino, and C. Prontera Cardiac natriuretic hormones, neuro-hormones, thyroid hormones and cytokines in normal subjects and patients with heart failure Clin Chem Lab Med 42 2004 627 636
15. A.A. Ajayi Estimation of creatinine clearance from serum creatinine: utility of the Cockroft and Gault equation in Nigerian patients Eur J Clin Pharmacol 40 1991 429 431
16. D.W. Cockcroft, and M.H. Gault Prediction of creatinine clearance from serum creatinine Nephron 16 1976 31 41
17. D.G. Waller, J.S. Fleming, B. Ramsey, and J. Gray The accuracy of creatinine clearance with and without urine collection as a measure of glomerular filtration rate Postgrad Med J 67 1991 42 46
18. National Kidney Foundation K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification Am J Kidney Dis 39 2002 S1 S266
19. M.J. Sarnak, A.S. Levey, and A.C. Schoolwerth American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention Hypertension 42 2003 1050 1065
20. S. Ljungman, J.H. Laragh, and R.J. Cody Role of the kidney in congestive heart failure: relationship of cardiac index to kidney function Drugs 39 Suppl. 4 1990 10 21
21. M. Packer Why do the kidneys release renin in patients with congestive heart failure? A nephrocentric view of converting-enzyme inhibition Eur Heart J 11 Suppl. D 1990 44 52
22. A. Clerico, and M. Emdin Diagnostic accuracy and prognostic relevance of the measurement of cardiac natriuretic peptides: a review Clin Chem 50 2004 33 50
23. C. DeFilippi, R.R. van Kimmenade, and Y.M. Pinto Amino-terminal pro-B-type natriuretic peptide testing in renal disease Am J Cardiol 101 3A 2008 82 88
24. R.R. van Kimmenade, J.L. Januzzi Jr., and A.L. Baggish Amino-terminal pro-brain natriuretic peptide, renal function, and outcomes in acute heart failure: redefining the cardiorenal interaction? J Am Coll Cardiol 48 2006 1621 1627
25. S. Masson, S. Solomon, and L. Angelici Elevated plasma renin activity predicts adverse outcome in chronic heart failure, independently of pharmacologic therapy: data from the Valsartan Heart Failure Trial (Val-HeFT) J Card Fail 16 2010 964 970
26. M.K. Szymanski, K. Damman, D.J. van Veldhuisen, W.H. van Gilst, H.L. Hillege, and R.A. de Boer Prognostic value of renin and prorenin in heart failure patients with decreased kidney function Am Heart J 162 2011 487 493
27. P.W. Craswell, V.M. Hird, R.A. Baillod, Z. Varghese, and J.F. Moorhead Significance of high plasma renin activity in patients on maintenance haemodialysis therapy Br Med J 2 1973 741 743
28. N.L. Yeyati, and H.J. Adrogué Inappropriately high plasma renin activity accompanies chronic loss of renal function Am J Nephrol 16 1996 471 477
29. H. Abboud, and W.L. Henrich Clinical practice. Stage IV chronic kidney disease N Engl J Med 362 2010 56 65
30. B.M. Brenner, M.E. Cooper, and D. de Zeeuw RENAAL Study Investigators. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy N Engl J Med 345 2001 861 869
31. E.J. Lewis, L.G. Hunsicker, R.P. Bain, and R.D. Rohde The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group N Engl J Med 329 1993 1456 1462
32. KDOQI clinical practice guidelines and clinical practice recommendations for diabetes and chronic kidney disease Am J Kidney Dis 49 2007 S12 S154
33. M. Azizi, and G. Wuerzner Rationale for combining blockers of the renin-angiotensin system Semin Nephrol 27 2007 544 554
34. W.H. Tang, R.H. Vagelos, and Y.G. Yee Neurohormonal and clinical responses to high- versus low-dose enalapril therapy in chronic heart failure J Am Coll Cardiol 39 2002 70 78
35. N.K. Hollenberg, N.D. Fisher, and D.A. Price Pathways for angiotensin II generation in intact human tissue: evidence from comparative pharmacological interruption of the renin system Hypertension 32 1998 387 392
36. J. Nussberger, G. Wuerzner, C. Jensen, and H.R. Brunner Angiotensin II suppression in humans by the orally active renin inhibitor Aliskiren (SPP100): comparison with enalapril Hypertension 39 2002 e1 e8